D. GORDON STRICKLAND - 27 Jan 2022 Form 4 Insider Report for NeuroBo Pharmaceuticals, Inc. (MTVA)

Role
Director
Signature
/s/ Jeffrey Kuras, by Power of Attorney
Issuer symbol
MTVA
Transactions as of
27 Jan 2022
Net transactions value
$0
Form type
4
Filing time
02 Feb 2022, 16:51:31 UTC
Next filing
10 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NRBO Non-qualified Stock Option (right to buy) Award $0 +40,000 $0.000000 40,000 27 Jan 2022 Common Stock 40,000 $1.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vests in thirty-six equal monthly installments beginning on the one-month anniversary of the date of grant, subject to the reporting person's continued service through each applicable vesting date.

Remarks:

Exhibit 24, Power of Attorney, is attached.